A Phase Ib Study of BKM120 With Weekly Cisplatin and Radiotherapy in High Risk Locally Advanced Squamous Cell Cancer of the Head and Neck
Phase of Trial: Phase I
Latest Information Update: 25 May 2017
At a glance
- Drugs Buparlisib (Primary) ; Cisplatin
- Indications Head and neck cancer
- Focus Adverse reactions
- 19 May 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.
- 06 Oct 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 02 Jul 2014 New trial record